NCT02510573

Brief Summary

The current study was designed to investigate the change of serum ficolin-3 levels and assess the prognostic predictive effect of serum ficolin-3 levels in the patients with severe traumatic brain injury.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2011

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 18, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 29, 2015

Completed
Last Updated

July 29, 2015

Status Verified

July 1, 2015

Enrollment Period

3.3 years

First QC Date

July 18, 2015

Last Update Submit

July 26, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mortality after severe traumatic brain injury

    Using structure telephone interviews, follow-up was performed by 1 doctor who was blinded to clinical information.

    Follow-up of 6 months

Secondary Outcomes (1)

  • Unfavorable outcome after severe traumatic brain injury

    Follow-up of 6 months

Study Arms (1)

sTBI group

The patients with isolated head trauma and postresuscitation GCS score of 8 or less.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The patients with isolated head trauma and postresuscitation Glasgow Coma Scale score of 8 or less.

You may qualify if:

  • Isolated head trauma
  • Postresuscitation Glasgow Coma Scale score of 8 or less.

You may not qualify if:

  • Less than 18 years of age
  • Admission time \> 6 hours
  • Previous head trauma
  • Neurological disease including ischemic or hemorrhagic stroke
  • Use of antiplatelet or anticoagulant medication
  • Diabetes mellitus
  • Hypertension
  • Presence of other prior systemic diseases including uremia, liver cirrhosis, malignancy, and chronic heart or lung disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

All blood samples from the patients at admission were collected in the tubes and centrifuged within 30 minutes at 1,000\*g for 15 minutes. The serum was removed and frozen at -70°C until measurement.

MeSH Terms

Conditions

Brain Injuries

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Neurosurgery

Study Record Dates

First Submitted

July 18, 2015

First Posted

July 29, 2015

Study Start

April 1, 2011

Primary Completion

July 1, 2014

Study Completion

February 1, 2015

Last Updated

July 29, 2015

Record last verified: 2015-07